Skip to main content

EagleClaw Capital Managment, LLC

Position in NVS — Novartis AG

CIK 1607636 BOSTON, MA

Position in NVS

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$3,716,144
-$383,055 QoQ
Shares Held
23,712
-11.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#317
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

EagleClaw Capital Managment, LLC holds $45,392,435 across 12 Drug Manufacturers - General names. NVS ranks #4 (8.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NVS
Novartis AG
This page
23,712 $3,716,144

All Filings in NVS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,716,144 23,712
2026-03-31 $4,099,199 26,836
2025-12-31 $3,816,517 27,682
2025-09-30 $3,601,235 28,082
2025-06-30 $3,014,117 24,908
2025-03-31 $2,776,743 24,908
2024-12-31 $2,445,789 25,134
2024-09-30 $2,580,358 22,434
2024-06-30 $2,585,274 24,284
2024-03-31 $2,348,991 24,284
2023-12-31 $2,385,315 23,624
2023-09-30 $2,375,782 23,324
2023-06-30 $2,277,942 22,574
2023-03-31 $2,145,808 23,324
2022-12-31 $2,206,128 24,318
2022-09-30 $1,863,613 24,518
2022-06-30 $2,104,205 24,893
2022-03-31 $2,177,077 24,810
2021-12-31 $2,183,251 24,960
2021-09-30 $2,008,516 24,560
2021-06-30 $2,181,548 23,910
2021-03-31 $1,879,277 21,985
2020-12-31 $2,076,043 21,985
2020-09-30 $1,911,815 21,985
2020-06-30 $1,843,747 21,110
2020-03-31 $1,818,847 22,060